Malignant Bone Tumors 1976
DOI: 10.1007/978-3-642-80997-2_4
|View full text |Cite
|
Sign up to set email alerts
|

Experimental Induction of Bone Tumors by Short-Lived Bone-Seeking Radionuclides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
14
0

Year Published

1980
1980
2008
2008

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 6 publications
0
14
0
Order By: Relevance
“…Osteosarcoma can be readily induced in mice by application of bone-seeking alpha-emitting radioisotopes, and are comparable to human osteosarcomas both histologically and pathobiologically (Gossner et al, 1976;Luz et al, 1991). Murine osteosarcomas are detectable at an early stage, limiting the opportunity for the development of complex genomic alterations, and increasing the likelihood that detected genetic alterations are biologically relevant.…”
Section: Introductionmentioning
confidence: 99%
“…Osteosarcoma can be readily induced in mice by application of bone-seeking alpha-emitting radioisotopes, and are comparable to human osteosarcomas both histologically and pathobiologically (Gossner et al, 1976;Luz et al, 1991). Murine osteosarcomas are detectable at an early stage, limiting the opportunity for the development of complex genomic alterations, and increasing the likelihood that detected genetic alterations are biologically relevant.…”
Section: Introductionmentioning
confidence: 99%
“…Exposure to therapeutic radiation, to radon or radium intake, and to Thoratrast (a bone-seeking isotope) has resulted in the development of osteosarcoma as well as leukemia and lymphoma. [15][16][17][18][19] However, an association between ionizing radiation and Ewing's sarcoma is less clear. 20 In animal experiments, beryllium exposure has produced osteosarcoma.…”
mentioning
confidence: 99%
“…Induction of osteosarcomas in mice with bone-seeking, short-lived radionuclides such as 224Ra or 22VTh represents a particularly powerful in vivo model to study late effects of incorporated e-emitters. Tumor incidence and tumor latency depend on the radiation dose and the dose rate [21], and the appearance of the tumors as well as the formation of metastases in mice resemble the findings in man [10].…”
Section: Introductionmentioning
confidence: 85%
“…These epidemiological data have been confirmed by internal irradiation in different animal models [10,45]. Induction of osteosarcomas in mice with bone-seeking, short-lived radionuclides such as 224Ra or 22VTh represents a particularly powerful in vivo model to study late effects of incorporated e-emitters.…”
Section: Introductionmentioning
confidence: 90%